338
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Integration of Chinese Herbal Medicine into Routine Care Was Related to Lower Risk of Chronic Kidney Disease in Patients with Rheumatoid Arthritis: A Population-Based Nested Case–Control Study in Taiwan

, , ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1191-1201 | Received 26 Dec 2022, Accepted 22 Feb 2023, Published online: 29 Apr 2023

References

  • Chiu HY, Huang HL, Li CH, et al. Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications - A national population-based cohort study. PLoS One. 2015;10(9):e0136508. doi:10.1371/journal.pone.0136508
  • Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15(Suppl 3):S2. doi:10.1186/ar4174
  • Lucas GNC, Leitão ACC, Alencar RL, et al. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019;41:124–130. doi:10.1590/2175-8239-jbn-2018-0107
  • Moller B, Pruijm M, Adler S, et al. Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis. 2015;74(4):718–723. doi:10.1136/annrheumdis-2013-204078
  • Lai KM, Chen TL, Chang CC, Chen HH, Lee YW. Association between NSAID use and mortality risk in patients with end-stage renal disease: a population-based cohort study. Clin Epidemiol. 2019;11:429–441. doi:10.2147/CLEP.S204322
  • Zhang Z, Cao H, Shen P, et al. Ping weisan alleviates chronic colitis in mice by regulating intestinal microbiota composition. J Ethnopharmacol. 2020;255:112715. doi:10.1016/j.jep.2020.112715
  • Lin MY, Chiu YW, Chang JS, et al. Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease. Kidney Int. 2015;88(6):1365–1373. doi:10.1038/ki.2015.226
  • Huang KC, Su YC, Sun MF, Huang ST. Chinese herbal medicine improves the long-term survival rate of patients with chronic kidney disease in Taiwan: a nationwide retrospective population-based cohort study. Front Pharmacol. 2018;9:1117. doi:10.3389/fphar.2018.01117
  • Zhang Q, Liu L, Lin W, et al. Rhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease. Kidney Int. 2017;91(1):144–156. doi:10.1016/j.kint.2016.07.040
  • Zeng JY, Wang Y, Miao M, Bao XR. The effects of rhubarb for the treatment of diabetic nephropathy in animals: a systematic review and meta-analysis. Front Pharmacol. 2021;12:602816. doi:10.3389/fphar.2021.602816
  • Pathan E, Gaitonde S, Rajadhyaksha S, et al. A longitudinal study of serum creatinine levels in patients of rheumatoid arthritis on long term NSAID therapy. J Assoc Physicians India. 2003;51:1045–1049.
  • National Health Insurance Administration, Ministry of Health and Welfare, Taiwan. Patients with catastrophic illnesses or rare disease. Available from: https://www.nhi.gov.tw/English/Content_List.aspx?n=F5B8E49CB4548C60&topn=1D1ECC54F86E9050. Accessed November 22, 2022.
  • Chiao YW, Livneh H, Guo HR, et al. Use of Chinese herbal medicines is related to a reduction in depression risk among patients with insomnia: a matched cohort study. Front Neurol. 2020;11:583485. doi:10.3389/fneur.2020.583485
  • Liu CY, Hung YT, Chuang YL, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4(1):1–22.
  • Lai NS, Livneh H, Fan YH, et al. Use of Chinese herbal medicines by rheumatoid arthritis patients was associated with lower risk of stroke: a retrospective cohort study. Complement Ther Med. 2019;45:124–129. doi:10.1016/j.ctim.2019.05.029
  • Pan MH, Chiou YS, Tsai ML, Ho CT. Anti-inflammatory activity of traditional Chinese medicinal herbs. J Tradit Complement Med. 2011;1(1):8–24. doi:10.1016/S2225-4110(16)30052-9
  • Tang Y, Liu Q, Feng Y, et al. Tripterygium ingredients for pathogenicity cells in rheumatoid arthritis. Front Pharmacol. 2020;11:583171. doi:10.3389/fphar.2020.583171
  • He YT, Ou AH, Yang XB, et al. Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study. Rheumatol Int. 2014;34(12):1647–1655. doi:10.1007/s00296-014-3010-6
  • Chang CP, Su YC, Lin MC, Huang ST. Chinese herbal medicine ameliorated the development of chronic kidney disease in patients with chronic hepatitis C: a retrospective population-based cohort study. Evid Based Complement Alternat Med. 2019;2019:5319456. doi:10.1155/2019/5319456
  • Bellomo R, Giantomasso DD. Noradrenaline and the kidney: friends or foes? Crit Care. 2001;5(6):294–298. doi:10.1186/cc1052
  • Tian B, Tian M, Huang SM. Advances in phytochemical and modern pharmacological research of Rhizoma corydalis. Pharm Biol. 2020;58(1):265–275. doi:10.1080/13880209.2020.1741651
  • Wu H, Waldbauer K, Tang L, et al. Influence of vinegar and wine processing on the alkaloid content and composition of the traditional Chinese medicine Corydalis Rhizoma (Yanhusuo). Molecules. 2014;19(8):11487–11504. doi:10.3390/molecules190811487
  • Pingali S, Donahue JP, Payton-Stewart F. Tetrahydroberberine, a pharmacologically active naturally occurring alkaloid. Acta Crystallogr C Struct Chem. 2015;71(Pt 4):262–265. doi:10.1107/S2053229615004076
  • Chen C, Wang F, Xiao W, et al. Effect on platelet aggregation activity: extracts from 31 traditional Chinese medicines with the property of activating blood and resolving stasis. J Tradit Chin Med. 2017;37(1):64–75. doi:10.1016/S0254-6272(17)30028-6
  • Khan IA, Nasiruddin M, Haque SF, Khan RA. Evaluation of rhubarb supplementation in stages 3 and 4 of chronic kidney disease: a randomized clinical trial. Int J Chronic Dis. 2014;2014:789340. doi:10.1155/2014/789340
  • Cao YJ, Pu ZJ, Tang YP, et al. Advances in bio-active constituents, pharmacology and clinical applications of rhubarb. Chin Med. 2017;12:36. doi:10.1186/s13020-017-0158-5
  • Xiang H, Zuo J, Guo F, Dong D. What we already know about rhubarb: a comprehensive review. Chin Med. 2020;15:88. doi:10.1186/s13020-020-00370-6
  • Dou F, Ding Y, Wang C, et al. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-beta/Smad signaling pathway. Biochem Pharmacol. 2020;180:114079. doi:10.1016/j.bcp.2020.114079
  • Guo C, Wang Y, Piao Y, Rao X, Yin D. Chrysophanol inhibits the progression of diabetic nephropathy via inactivation of TGF-beta pathway. Drug Des Devel Ther. 2020;14:4951–4962. doi:10.2147/DDDT.S274191
  • Chen Y, Miao Y, Huang L, et al. Antioxidant activities of saponins extracted from Radix trichosanthis: an in vivo and in vitro evaluation. BMC Complement Altern Med. 2014;14:86. doi:10.1186/1472-6882-14-86
  • Jiandong L, Yang Y, Peng J, et al. Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage. Biomed Pharmacother. 2019;109:93–102. doi:10.1016/j.biopha.2018.10.060
  • Zhang Q, Xiao X, Zheng J, et al. Shenqi jiangtang granule ameliorates kidney function by inhibiting apoptosis in a diabetic rat model. Evid Based Complement Alternat Med. 2019;2019:3240618. doi:10.1155/2019/3240618
  • Xu X, Zheng N, Chen Z, et al. Puerarin, isolated from pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress. Gene. 2016;591(2):411–416. doi:10.1016/j.gene.2016.06.032
  • Jin SE, Son YK, Min B-S, et al. Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots. Arch Pharm Res. 2012;35(5):823–837. doi:10.1007/s12272-012-0508-x
  • Tan Y-Q, Chen H-W, Li J, Wu Q-J. Efficacy, chemical constituents, and pharmacological actions of radix paeoniae rubra and radix paeoniae alba. Front Pharmacol. 2020;11:1054. doi:10.3389/fphar.2020.01054
  • Okubo T, Nagai F, Seto T, et al. The inhibition of phenylhydroquinone-induced oxidative DNA cleavage by constituents of moutan cortex and paeoniae radix. Biol Pharm Bull. 2000;23(2):199–203. doi:10.1248/bpb.23.199
  • Ye J, Duan H, Yang X, Yan W, Zheng X. Anti-thrombosis effect of paeoniflorin: evaluated in a photochemical reaction thrombosis model in vivo. Planta Med. 2001;67(8):766–767. doi:10.1055/s-2001-18364
  • Li B, Yang ZB, Lei SS, et al. Combined antihypertensive effect of paeoniflorin enriched extract and metoprolol in spontaneously hypertensive rats. Pharmacogn Mag. 2018;14(53):44–52. doi:10.4103/pm.pm_483_16
  • Su-Hong C, Qi C, Bo L, et al. Antihypertensive effect of radix paeoniae alba in spontaneously hypertensive rats and excessive alcohol intake and high fat diet induced hypertensive rats. Evid Based Complement Alternat Med. 2015;2015:731237. doi:10.1155/2015/731237
  • Chen W, Chen HY, Yang YH, et al. An investigation of the prescription patterns of Chinese herbal products for chronic glomerulonephritis patients: a hospital-based cross-sectional study. Evid Based Complement Alternat Med. 2018;2018:5080764. doi:10.1155/2018/5080764
  • Ren D, Luo J, Li Y, et al. Saikosaponin B2 attenuates kidney fibrosis via inhibiting the hedgehog pathway. Phytomedicine. 2020;67:153163. doi:10.1016/j.phymed.2019.153163
  • Yasui T, Yamada M, Uemura H, et al. Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine. Maturitas. 2009;62(2):146–152. doi:10.1016/j.maturitas.2008.12.007
  • Chen YH, Luo R, Lei SS, et al. Anti-inflammatory effect of ganluyin, a Chinese classic prescription, in chronic pharyngitis rat model. BMC Complement Med Ther. 2020;20(1):265. doi:10.1186/s12906-020-03057-5
  • Guo RB, Wang GF, Zhao AP, et al. Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-IoB-mediated inflammatory responses. PLoS One. 2012;7(11):e49701. doi:10.1371/journal.pone.0049701